Mylan NV (NASDAQ:MYL) confirmed that its subsidiary firm, Mylan Pharmaceuticals Private Limited, introduced generic Sofosbuvir 400 mg tablets in India….

Merck & Co., Inc. (NYSE:MRK) reaffirmed its deep commitment to discovering and formulating novel medications in the global fight against severe infectious…

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has been facing a lot of troubles due to its cancer drug, Iclusig. The CEO of Ariad, Harvey J. Berger, has been…

AbbVie Inc (NYSE:ABBV) disclosed its decision to extend the deadline date of its exchange offer to acquire Pharmacyclics, Inc. (NASDAQ:PCYC). The company…

The Journal of the ‘American College of Cardiology’ reported data confirming the long-term efficacy and safety of the Boston Scientific Corporation…

Rite Aid Corporation (NYSE:RAD) has filed a lawsuit against Medicis Pharmaceutical Corp. stating that the company has been involved in malpractice. The…

A trial of Bristol-Myers Squibb Co (NYSE:BMY) Opdivo treatment has been concluded after proving it is effective against one of the most common forms of…

Merck & Co., Inc. (NYSE:MRK)‘s Keytruda was shown in a study to reduce tumors in almost half of advanced lung cancer patients. Now, the company…

Celgene Corporation (NASDAQ:CELG) has made a deal to purchase $45 million worth of Mesoblast’s shares. The top dollar buy off was a strategy for Celgene…